Novel treatment strategies for aggressive non-Hodgkin’s lymphoma

Author： Fayad Luis   Younes Anas  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 733-748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin’s Lymphoma

By Limat Samuel   Demesmay Karine  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 719-729

Adis International

Access to resources Recommend Favorite

Treatment advances in non-Hodgkin’s lymphoma

By Tan B.R.   Bartlett N.L.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 451-465

Informa Healthcare

Access to resources Recommend Favorite

The role of pixantrone in the treatment of non-Hodgkin’s lymphoma

By Borchmann Peter  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1055-1061

Informa Healthcare

Access to resources Recommend Favorite

Gallium nitrate for the treatment of non-Hodgkin’s lymphoma

By Chitambar Christopher R  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 531-541

Informa Healthcare

Access to resources Recommend Favorite

Aggressive Non-Hodgkin’s Lymphoma: Economics of High-Dose Therapy

By Beard S.M.  

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 207-224

Adis International

Access to resources Recommend Favorite